These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6219691)

  • 1. Low dose prednisolone or oestrogen in the treatment of women with late onset or persistent acne vulgaris.
    Darley CR; Moore JW; Besser GM; Munro DD; Kirby JD
    Br J Dermatol; 1983 Mar; 108(3):345-53. PubMed ID: 6219691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen excess in cystic acne.
    Marynick SP; Chakmakjian ZH; McCaffree DL; Herndon JH
    N Engl J Med; 1983 Apr; 308(17):981-6. PubMed ID: 6220224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
    Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Androgenic evaluation of women with late-onset or persistent acne].
    Maneschi F; Noto G; Pandolfo MC; Palisi F; Martorana A
    Minerva Ginecol; 1989 Feb; 41(2):99-103. PubMed ID: 2526307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
    Rosen MP; Breitkopf DM; Nagamani M
    Am J Obstet Gynecol; 2003 May; 188(5):1158-60. PubMed ID: 12748463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea.
    Wang HS; Wang TH; Soong YK
    Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):423-32. PubMed ID: 10584414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].
    Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F
    Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives in the treatment of acne.
    Tan JK; Degreef H
    Skin Therapy Lett; 2001 Feb; 6(5):1-3. PubMed ID: 11242137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris.
    Darley CR; Kirby JD; Besser GM; Munro DD; Edwards CR; Rees LH
    Br J Dermatol; 1982 May; 106(5):517-22. PubMed ID: 6462165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hormone levels in men with severe acne.
    Aizawa H; Niimura M
    J Dermatol; 1992 Jul; 19(7):404-7. PubMed ID: 1401498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy.
    Saihan EM; Burton JL
    Br J Dermatol; 1980 Aug; 103(2):139-42. PubMed ID: 6448623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of androgens in women with adult-onset acne.
    Seirafi H; Farnaghi F; Vasheghani-Farahani A; Alirezaie NS; Esfahanian F; Firooz A; Ghodsi SZ
    Int J Dermatol; 2007 Nov; 46(11):1188-91. PubMed ID: 17988341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen status in women with late onset or persistent acne vulgaris.
    Darley CR; Moore JW; Besser GM; Munro DD; Edwards CR; Rees LH; Kirby JD
    Clin Exp Dermatol; 1984 Jan; 9(1):28-35. PubMed ID: 6229368
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the subject of hormone therapy of polymorphous feminine acne: clinical results and behavior of the sebaceous secretion with the use of a progestin-estrogen combination].
    Bonelli M; Alessi E
    G Ital Dermatol Minerva Dermatol; 1966; 107(1):15-34. PubMed ID: 4224764
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
    Leelaphiwat S; Jongwutiwes T; Lertvikool S; Tabcharoen C; Sukprasert M; Rattanasiri S; Weerakiet S
    J Obstet Gynaecol Res; 2015 Mar; 41(3):402-10. PubMed ID: 25319761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment.
    Greenwood R; Brummitt L; Burke B; Cunliffe WJ
    Br Med J (Clin Res Ed); 1985 Nov; 291(6504):1231-5. PubMed ID: 2933119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Androgens and SHBG in women with late-appearing or persistent acne].
    Peserico A; Ruzza G; Cipriani R; Pellizzari AA
    G Ital Dermatol Venereol; 1985; 120(1):17-8. PubMed ID: 3159654
    [No Abstract]   [Full Text] [Related]  

  • 20. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
    Redmond GP; Olson WH; Lippman JS; Kafrissen ME; Jones TM; Jorizzo JL
    Obstet Gynecol; 1997 Apr; 89(4):615-22. PubMed ID: 9083323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.